Beranda › Fibrosis Kistik › Kansas › Kansas City
Uji klinis Fibrosis Kistik di Kansas City, KS
13 studi untuk Fibrosis Kistik mencari peserta di lokasi sekitar Kansas City (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Phase 2 Study to Assess the Safety and Efficacy of ANG003
Menerima pesertaFase 2
- University of Kansas Medical Center, Kansas City
Sinus Disease in Young Children With Cystic Fibrosis
Menerima pesertaStudi observasional
- University of Kansas Medical Center, Kansas City
Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children
Menerima pesertaStudi observasional
- University of Kansas Medical Center, Kansas City
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
Menerima pesertaFase 4
- University of Kansas Medical Center, Kansas City
4D-710 in Adult Patients With Cystic Fibrosis
Menerima pesertaFase 2
- University of Kansas Medical Center, Kansas City
Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Muco-Obstructive Lung Disease
Menerima pesertaStudi observasional
- University of Kansas Medical Center, Kansas City
Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
Menerima pesertaFase 1Sukarelawan sehat diterima
- University of Kansas Medical Center, Kansas City
Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function
Menerima pesertaFase 2
- University of Kansas Medical Center, Kansas City
Health Outcomes of Parents With Cystic Fibrosis-Aim 2
Menerima pesertaStudi observasional
- University of Kansas Medical Center, Kansas City
Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
Menerima pesertaStudi observasional
- Kansas University Medical Center, Kansas City
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
Menerima pesertaStudi observasional
- University of Kansas Medical Center, Kansas City
Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.
Menerima pesertaFase 2
- University of Kansas Medical Center, Kansas City
A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)
Menerima pesertaFase 1/2
- University of Kansas Medical Center, Kansas City
Uji klinis Fibrosis Kistik di kota lain
- Boston, MA17 studi
- Birmingham, AL16 studi
- Philadelphia, PA15 studi
- Seattle, WA12 studi
- Baltimore, MD12 studi
- Denver, CO11 studi
- Pittsburgh, PA11 studi
- Dallas, TX11 studi
- Cincinnati, OH10 studi
- Los Angeles, CA9 studi
- Aurora, CO9 studi
- Charleston, SC8 studi
Studi lain di Kansas City
- Penyakit Kardiovaskular14 studi
- Gagal Jantung13 studi
- Obesitas13 studi
- Penyakit Paru Interstisial13 studi
- Kanker Payudara12 studi
- Kanker Kandung Kemih12 studi
- Leukemia Mieloid Akut12 studi
- Kanker Prostat12 studi
- Kanker Paru Non-Sel Kecil11 studi
- Kanker Paru11 studi
- PPOK9 studi
- Asma8 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.